EP2238250
USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.12.2008EP published:
19.7.2017EP application number:
08866608.6
EPO information:
European Patent Register
Max expiry date:
21.12.2028Expiry date:
21.12.2018
Title:
USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS
Timeline
Today
22.12.2008EP application
19.7.2017EP Publication
21.12.2018Expires
Owner
Name:
Ocunexus Therapeutics, Inc.Address:
12481 High Bluff Drive, Suite 150, 92130, San Diego CA, US
Inventor
Name:
BECKER, David, L.Address:
Abbots LangleyHertfordshire, GB
Name:
GREEN, Colin, R.Address:
Auckland, NZ
Name:
DUFT, Bradford, J.Address:
Rancho Santa FeCA, US
Priority
Number:
8660 PDate:
21.12.2007Country:
US
Classification
Categories:
C12N 15/113, A61K 38/17, A61P 41/00, A61P 19/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 9.11.2017
Expires: 21.12.2018
Payer: Árnason Faktor